EUVIMEDEUVIMED entdecken
Open Access

Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma

Ning Xu, Zhihong Zhang, Jin Zhu, Lu Xu, Yuhua Li, Lei Duan, Yuan Mao, Hongxia Li

International Journal of Experimental Pathology · 2016-04 · 97 (2) · 150-158

DOI: 10.1111/iep.12174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Experimental Pathology, online erschienen am 29.04.2016. Verfasst von Ning Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Medical University, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most patients with epithelial ovarian cancer ( EOC ) are diagnosed at an advanced stage, and therapeutic options for these patients are limited. The identification of suitable biomarkers could be helpful for patients with EOC , who might benefit from targeted therapies even in advanced stages of the disease. Trophoblast cell surface antigen 2 ( TROP 2) is highly expressed in various human malignant tumours; however, this has not been demonstrated clearly in EOC . In this study, we further evaluated whether TROP 2 is a promising marker for EOC, and thus also a potential target for EOC immunotherapy. Quantitative real‐time polymerase chain reaction (qPCR) and fluorescence‐activated cell sorting (FACS) analysis were employed to determine TROP 2 mRNA and protein expression in both human EOC and normal ovarian cell lines. Additionally, TROP 2 protein expression was measured by immunohistochemistry in 128 EOC tissue samples, 21 normal ovarian tissues and 18 normal fallopian tubes. The correlations between TROP 2 protein expression and patients' clinicopathological features were investigated, and survival outcomes were analysed. TROP 2 mRNA and protein levels were upregulated significantly in EOC cell lines compared with normal cell lines. The protein of TROP 2 was expressed in the majority of EOC tissue samples (90.6%) and overexpressed in 75 (58.6%) of the 128 tumour samples. TROP 2 overexpression was correlated with relevant clinicopathological characteristics and was associated with significantly shortened overall survival and disease‐free survival. Furthermore, TROP 2 was an independent prognostic marker for EOC s as analysed by Cox regression. TROP 2 was a potential biomarker for targeted therapy in patients with TROP 2‐overexpressing EOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAntigens, NeoplasmBiomarkers, TumorCarcinoma, Ovarian EpithelialCell Adhesion MoleculesCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateLymphatic MetastasisMiddle AgedMolecular Targeted TherapyNeoplasm GradingNeoplasm ProteinsNeoplasms, Glandular and EpithelialOvarian NeoplasmsPrognosisRNA, Messenger

Stichwörter der Autor:innen

TROP2biomarker targeted therapyepithelial ovarian cancerimmunohistochemistryindependent prognostic marker

Substanzen

Antigens, NeoplasmBiomarkers, TumorCell Adhesion MoleculesNeoplasm ProteinsRNA, MessengerTACSTD2 protein, human

Autor:innen und Institutionen

  • Nanjing Medical University, Nanjing, Jiangsu, China.
  • The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
  • Huadong Medical Insitute of Biotechniques, Nanjing, Jiangsu, China.
  • Jiangsu Provincial Hospital, Nanjing, Jiangsu, China.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Xu, N., Zhang, Z., Zhu, J., Xu, L., Li, Y., Duan, L., Mao, Y., & Li, H. (2016). Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. International Journal of Experimental Pathology, 97(2), 150-158. https://doi.org/10.1111/iep.12174

Vancouver

Xu N, Zhang Z, Zhu J, Xu L, Li Y, Duan L, et al. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. International Journal of Experimental Pathology. 2016;97(2):150-158. doi:10.1111/iep.12174

BibTeX
@article{Xu2016,
  author = {Xu, Ning and Zhang, Zhihong and Zhu, Jin and Xu, Lu and Li, Yuhua and Duan, Lei and Mao, Yuan and Li, Hongxia},
  title = {Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma},
  journal = {International Journal of Experimental Pathology},
  year = {2016},
  volume = {97},
  number = {2},
  pages = {150--158},
  doi = {10.1111/iep.12174}
}
Kostenlos starten →